Legal Opinion
United States ex rel. Polansky v. Pfizer, Inc.
Court of Appeals for the Second Circuit
Decided May 17, 2016No. Docket No. 14-4774PublishedCited by 20 opinions
1Opinion of the Court
DENNIS JACOBS, Circuit Judge:
Dr. Jesse Polansky appeals from a partial final ¿judgment of the United States District Court for the Eastern District of New York (Cogan, /.), dismissing his False Claims Act (“FCA”) and state analog causes of action. We have appellate jurisdiction by virtue of certification. Polansky alleges that in and after 2002: his former employer, defendant Pfizer, Inc. (“Pfizer”), improperly marketed Lipitor, a popular statin, as appropriate for patients whose risk factors and cholesterol levels fall outside the National Cholesterol Education Program Guidelines (“NCEP…
2Cases cited11 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Wyeth v. LevineSupreme Court of the United States · 2009
- United States Ex Rel. Grubbs v. KannegantiCourt of Appeals for the Fifth Circuit · 2009
- United States Ex Rel. Nathan v. Takeda Pharmaceuticals North America, Inc.Court of Appeals for the Fourth Circuit · 2013
- United States v. Community Health Systems, Inc.Court of Appeals for the Sixth Circuit · 2007
6 more not listed; retrieve them via the Exa API.
3Cited by20 opinions
- United States Ex Rel. Chorches v. American Medical Response, Inc.Court of Appeals for the Second Circuit · 2017
- United States Ex Rel. Ibanez v. Bristol-Myers Squibb Co.Court of Appeals for the Sixth Circuit · 2017
- L. W. v. Jonathan SkrmettiCourt of Appeals for the Sixth Circuit · 2023
- United States v. FacteauCourt of Appeals for the First Circuit · 2023
- Catalyst Pharmaceuticals, Inc. v. Xavier BecerraCourt of Appeals for the Eleventh Circuit · 2021
15 more not listed; retrieve them via the Exa API.